CONTRACTING ORGANIZATION: Veterans Medical Research Foundation San Diego, CA

Similar documents
CONTRACTING ORGANIZATION: University of California Lawrence Berkeley National Laboratory Berkeley, CA 94720

CONTRACTING ORGANIZATION: North Eastern Ohio Universities Rootstown OH 44202

TITLE: Dietary Genistein and Prostate Cancer Chemoprevention

TITLE: New Advanced Technology to Improve Prediction and Prevention of Type 1 Diabetes

Fort Detrick, Maryland

U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

CONTRACTING ORGANIZATION: Western Institute For Biomedical Research Salt Lake City, UT

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

Award Number: W81XWH

TITLE: Neural Protein Synuclein (SNCG) in Breast Cancer Progression

TITLE: Genes Associated with Food Allergy and Eosinophilic Esophagitis

CONTRACTING ORGANIZATION: Sloan-Kettering Institute for Cancer Research New York, NY 10021

U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

Approved for public release; distribution unlimited

TITLE: Prazosin for Treatment of Patients With PTSD and Comorbid Alcohol Dependence

Award Number: W81XWH

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

AD (Leave blank) TITLE: Brief cognitive behavioral therapy for military populations

TITLE: Evaluation of DNA Methylation as a Target for Intraductal Therapy for Ductal Carcinoma in Situ of the Breast

TITLE: Short-Term Exercise and Prostate Cancer Prevention in African American Men. CONTRACTING ORGANIZATION: Howard University Washington DC 20059

TITLE: Oxidative Stress, DNA Repair and Prostate Cancer Risk. PRINCIPAL INVESTIGATOR: Hua Zhao, Ph.D.

AWARD NUMBER: W81XWH TITLE: Gulf War Illness as a Brain Autoimmune Disorder. PRINCIPAL INVESTIGATOR: Apostolos Georgopoulos, MD, PhD

AD (Leave blank) TITLE: Proteomic analyses of nipple fluid for early detection of breast cancer

TITLE: Maximizing Energy After Traumatic Brain Injury: A Novel Intervention

AWARD NUMBER: W81XWH TITLE: Treatment of Pain and Autonomic Dysreflexia in Spinal Cord Injury with Deep Brain Stimulation

TITLE: 64Cu-DOTA-trastuzumab PET imaging in women with HER2 overexpressing breast cancer

TITLE: Computerized Tailored Interventions for Behavioral Sequelae of Post-Traumatic Stress Disorder in Veterans

TITLE: Homeostatic and Circadian Abnormalities in Sleep and Arousal in Gulf War Syndrome

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Responsiveness of a Neuromuscular Recovery Scale for Spinal Cord Injury: Inpatient and Outpatient Rehabilitation

TITLE: Demonstrating the Efficacy of Group Prolonged Exposure Treatment of PTSD in OEF/OIF/OND Male Veterans

Approved for public release; distribution unlimited

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

CONTRACTING ORGANIZATION: Johns Hopkins Bloomberg School of Public Health

Award Number: W81XWH TITLE: Global Positioning Systems (GPS) Technology to Study Vector-Pathogen-Host Interactions

AD (Leave blank) Award Number: W81XWH TITLE: Targeting Autophagy for the Treatment of TSC and LAM. PRINCIPAL INVESTIGATOR: Elizabeth Henske

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Adipose Estrogen and Increased Breast Cancer Risk in Obesity: Regulation by Leptin and Insulin

TITLE: Determination of Optimum Vitamin D Nutrition in Young Women. Omaha, NE 68178

TITLE: Improving Work Outcomes for Veterans with Traumatic Brain Injury. San Diego, CA 92161

TITLE: Long Term Outcomes of BRCA1/BRCA2 Mutation Testing. CONTRACTING ORGANIZATION: Georgetown University Washington, DC

Sphingosine-1-Phosphate Receptor Subtype 3: A Novel Therapeutic Target of K-Ras Mutant Driven Non-Small Cell Lung Carcinoma

Detection of Prostate Cancer Progression by Serum DNA Integrity

Page 1 AWARD NUMBER: W81XWH TITLE: A Novel Pleiotropic Anti-Inflammatory Drug to Reduce ARDS Incidence. PRINCIPAL INVESTIGATOR: Gary Nieman

AWARD NUMBER: W81XWH TITLE: Androgen Deprivation Therapy and Cognitive Impairment. PRINCIPAL INVESTIGATOR: Robert N. Pechnick, Ph.D.

CONTRACTING ORGANIZATION: Oregon Health & Science University Portland OR 97239

TITLE: Enhancing the Anti-Tumor Activity of ErbB Blockers with Histone Deaccetylase (HDAC) Inhibition in Prostate Cancer Cell Lines

TITLE: A Placebo-Controlled Augmentation Trial of Prazosin for Combat Trauma PTSD

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland X Approved for public release; distribution unlimited

TITLE: Using Propranolol to Block Memory Reconsolidation in Female Veterans with PTSD

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Prevention and Treatment of Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Targeting the Immune System s Natural Response to Cell Death to Improve Therapeutic Response in Breast Cancers

TITLE: Targeted Eradication of Prostate Cancer Mediated by Engineered Mesenchymal Stem Cells

TITLE: Effect of Reminder Telephone Calls on Mammography Compliance in High Risk

TITLE: Investigation of the Akt/PKB Kinase in the Development of Hormone-Independent Prostate Cancer

CONTRACTING ORGANIZATION: University of Minnesota St Paul, MN 55108

CONTRACTING ORGANIZATION: Cold Spring Harbor Laboratory Cold Spring Harbor, NY 11724

CONTRACTING ORGANIZATION: Regents of the University of Michigan Ann Arbor, MI 48109

TITLE: Post-Traumatic Headache and Psychological Health: Mindfulness Training for Mild Traumatic Brain Injury

TITLE: Properties of Leukemia Stem Cells in a Novel Model of CML Progression to Lymphoid Blast Crisis

Award Number: W81XWH TITLE: A Novel Membrane-Permeable, Breast-Targeting, Pro-Apoptotic Peptide for Treatment of Breast Cancer

TITLE: The Role Of Alternative Splicing In Breast Cancer Progression

Promote Adjustment during Reintegration following Deployment

TITLE: Role of ADAM15 in Tumor/Endothelial Interactions Prostate Cancer Regression

CONTRACTING ORGANIZATION: UNIVERSITY OF ILLINOIS Chicago, IL 60612

TITLE: Gulf War Illness Evaluation of an innovative detoxification program

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Selective Oncolytic Therapy for Hypoxic Breast Cancer Cells. CONTRACTING ORGANIZATION: Ordway Research Institute Albany, New York 12208

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

CONTRACTING ORGANIZATION: Spaulding Rehabilitation Hospital, Boston, MA 02129

TITLE: MicroRNA in Prostate Cancer Racial Disparities and Aggressiveness

TITLE: Proteomic Mapping of the Immune Response to Gluten in Children with Autism

TITLE: Inhibitors of Histone Deacetylases for Radiosensitization of Prostate Cancer

AD (Leave blank) TITLE: Trial of Naltrexone and Dextromethorphan for Gulf War Veterans Illnesses

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: A Phase II Trial of Androgen Suppression and Radiation Therapy with Samarium-1 53 in Localized, High-Risk, Prostate Cancer

CONTRACTING ORGANIZATION: West Virginia University Morgantown, West Virginia

CONTRACTING ORGANIZATION: Mount Sinai School of Medicine New York, New York

Award Number: W81XWH TITLE: "Longitudinal Study of a Novel Performance-based Measure of Daily Function."

CONTRACTING ORGANIZATION: Cleveland Clinic Foundation Cleveland, OH 44195

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, MD

TITLE: A Tissue Engineering Approach to Study the Progression of Breast Tumor Metastasis in Bone

TITLE: Breast Density Assessment by Dual Energy X-ray Absorptiometry in Women and Girls. Rachel Novotny, Ph.D. Honolulu, HI 96822

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Identification of New Serum Biomarkers for Early Breast Cancer Diagnosis and Prognosis Using Lipid Microarrays.

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

Award Number: W81XWH TITLE: Regenerative Stem Cell Therapy for Breast Cancer Bone Metastasis

CONTRACTING ORGANIZATION: Fred Hutchinson Cancer Research Center Seattle, WA 98109

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Developing a Training Program in Breast Cancer Research to Decrease the Disparity of Morbidity and Mortality in Underserved/Minority Women

La Jolla, CA Approved for Public Release; Distribution Unlimited

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Prostate Expression Databases: Gene Expression Resources for Comparative Studies of Prostate Carcinogenesis

TITLE: The Role of HOX Proteins in Androgen-Independent Prostate Cancer

TITLE: Harnessing GPR17 Biology for Treating Demyelinating Disease

TITLE: Effects of Tobacco Smoke (TS) on growth of clear cell renal cell carcinoma (ccrcc)

Award Number: W81XWH TITLE: Dietary Fish Oil in Reducing Bone Metastasis of Breast Cancer

Transcription:

Award Number: W81XWH-11-2-0001 TITLE: Role of Sleep Deprivation in Fear Conditioning and Extinction: Implications for Treatment of PTSD PRINCIPAL INVESTIGATOR: Victoria Risbrough, PhD CONTRACTING ORGANIZATION: Veterans Medical Research Foundation San Diego, CA 92161-0002 REPORT DATE: October 2015 TYPE OF REPORT: Annual PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012 DISTRIBUTION STATEMENT: X Approved for public release; distribution unlimited The views, opinions and/or findings contained in this report are those of the author(s) and should not be construed as an official Department of the Army position, policy or decision unless so designated by other documentation.

REPORT DOCUMENTATION PAGE Form Approved OMB No. 0704-0188 Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information Operations and Reports (0704-0188), 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS. 1. REPORT DATE (DD-MM-YYYY) 2. REPORT TYPE 3. DATES COVERED (From - To) October 2015 Annual 1 OCT 2014-30 SEP 2015 4. TITLE AND SUBTITLE Role of Sleep Deprivation in Fear Conditioning and Extinction: Implications for Treatment of PTSD 5a. CONTRACT NUMBER 5b. GRANT NUMBER W81XWH-11-2-0001 5c. PROGRAM ELEMENT NUMBER 6. AUTHOR(S) Victoria Risbrough, PhD email: vrisbrough@ucsd.edu 7. PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) Veterans Medical Research Foundation 3350 La Jolla Village Dr. Mail Code 151A San Diego, CA 92161 5d. PROJECT NUMBER 5e. TASK NUMBER 5f. WORK UNIT NUMBER 8. PERFORMING ORGANIZATION REPORT NUMBER 9. SPONSORING / MONITORING AGENCY NAME(S) AND ADDRESS(ES) 10. SPONSOR/MONITOR S ACRONYM(S) U.S. Army Medical Researcn and Materiel Command Fort Detrick, Maryland 21702-5012 11. SPONSOR/MONITOR S REPORT NUMBER(S) 12. DISTRIBUTION / AVAILABILITY STATEMENT Approved for public release; distribution unlimited 13. SUPPLEMENTARY NOTES 14. ABSTRACT PTSD is a growing concern for both active duty personnel and Veterans. Fear conditioning is implicated in the development of PTSD, while successful acquisition, consolidation, and recall of extinction memory are implicated in both the natural reduction of initial PTSD symptoms and as the mechanism underlying the most successful treatment for PTSD, Prolonged Exposure. This project is the first to examine the role of sleep and sleep loss in acquisition, consolidation, and generalization of extinction memory in humans. Our main finding is that sleep loss most strongly affects recall of extinction learning, and that the REM sleep stage is associated with ability to recall extinction as well as recall safety signal learning. These findings suggest that sleep plays a critical role in long term retention of fear inhibition processes, and efforts to support sleep and especially adequate REM during exposure therapy may enhance efficacy and reduce remission after treatment. 15. SUBJECT TERMS PTSD, sleep deprivation, fear conditioning, extinction memory, humans 16. SECURITY CLASSIFICATION OF: 17. LIMITATION OF ABSTRACT a. REPORT U b. ABSTRACT U c. THIS PAGE U 18. NUMBER OF PAGES 19a. NAME OF RESPONSIBLE PERSON USAMRMC UU 20 19b. TELEPHONE NUMBER (include area code) Standard Form 298 (Rev. 8-98) Prescribed by ANSI Std. Z39.18

Table of Contents Page Introduction..... 4 Body.. 4 Key Research Accomplishments... 5 Reportable Outcomes 5 Conclusion 6 References. 7 Appendices 7 Supporting Data 7

Introduction PTSD is a growing concern for both active duty personnel and Veterans. Fear conditioning is implicated in the development of PTSD, while successful acquisition, consolidation, and recall of extinction memory are implicated in both the natural reduction of initial PTSD symptoms and as the mechanism underlying the most successful treatment for PTSD, Prolonged Exposure. In animal models, sleep deprivation has been shown to impair extinction memory. Indirect evidence in humans also supports that notion, but it has never been tested directly in humans. Some of the most ubiquitous and distressing symptoms of PTSD are insomnia and nightmares. The resultant sleep deprivation may actually serve to perpetuate the disorder by interfering with treatments designed to promote extinction memories. Before this hypothesis can be tested in clinical populations, however, well-controlled experimental studies need to establish the exact role of sleep deprivation in extinction acquisition, consolidation, and recall in humans. This study will do just that. This is a mixed-effects study designed to examine the impact of 36 hours TSD on fear conditioning and consolidation (Aim 1), as well as extinction memory acquisition, recall, and generalization (Aim 2). A total of 60 subjects will participate across 3 years. Following recruitment and screening, subjects will spend 4 nights and days in the laboratory: a) adaptation to the lab (Night/Day0); b) normal sleep followed by fear memory acquisition (Night/Day1); c) sleep or TSD followed by fear recall and extinction memory acquisition (Night/Day2); and d) sleep or TSD followed by a test of extinction recall and generalization (Night/Day3). Group1 will receive sleep prior to each testing day, Group2 will be sleep deprived prior to Day2, and Group3 will be sleep deprived prior to Day3. Body This report covers the second No Cost Extension year of the project. This year focused on data processing and analysis, as well as dissemination and publication of our findings. Specific activities include: a. Data Processing. As describe in a series of quarterly reports, we were finally able to continue spending on the project once the PI change was accepted, and hired data cleaners and a statistician to finalize all data cleaning and analysis (EMG and sleep variables). b. Data Analysis. We have completed our data analysis for our 3 rd manuscript, which will be submitted in November to Proceedings of the National Academy of Sciences. c. Dissemination. Ms. Straus has made national presentations of our study findings. Straus, L.D., Acheson, D., Risbrough, V.B., & Drummond, S.P.A. (2015 June). The Effect of 36 hours of Total Sleep Deprivation on Extinction Learning and Recall. Oral presentation at the 28th Annual Meeting of the Associated Professional Sleep Societies. Seattle, Washington (see attached slides) d. Manuscripts. We have published two manuscripts, thus far from this study (reported last year), and will submit a third in November. 4

e. In addition to the submission of the 3 rd paper, we are also currently working on a fourth paper to identify physiological sleep variables that impinge on extinction and safety recall (i.e. sympathetic responding via measures of heart rate variability during sleep). Key Research Accomplishments Data collection and analysis of all primary aims completed. Our study findings were presented at sleep conferences (see above). We published two manuscripts and the 3 rd manuscript is being submitted in November. Reportable Outcomes We are finalizing our 3 rd manuscript which we think will provide important new insights into how sleep affects fear extinction. In brief, we found that sleep deprivation before extinction training does not alter learning but does significantly reduce recall of extinction 24 hrs later. We did not find effects of sleep deprivation after extinction learning (before recall), suggesting that sleep before extinction training is the critical component to supporting long term fear inhibition (Figure 1). We also found that the amount of fear inhibition on day 3 (recall testing) was significantly associated with amount of REM consolidation, suggesting that REM sleep in particular may play an important role in retaining fear extinction memory (Figure 2). Startle to CS+ Above Baseline (Z Score) 1.0 0.8 0.6 0.4 0.2 0.0 * Normal Pre-ext Dep Post-ext Dep Figure 1: Pre-extinction training sleep deprivation reduces extinction recall. Standardized potentiated startle magnitudes by sleep group across the final recall session (day 3 of testing). *=p<.05 for a priori comparison with the normal sleep group. Normal = normal sleep group; Preext Dep = pre-extinction sleep deprivation group, and Post-ext Dep = post-extinction sleep deprivation group. Note groups did not differ on level of fear conditioning, cued fear recall or extinction training sessions. 5

Figure 2: Relationship between REM sleep consolidation on Night 2 and extinction recall on Day 3, by group. Higher scores on REM consolidation on Night 2 corresponded to reduced fear responsiveness to the CS+ on Day 3, indicating enhanced extinction recall. Conclusion This past year, we were able to finalize data analysis for two more manuscripts, have reached completion of one manuscript for submission and are actively writing a fourth.. There are two major implications of our findings. First, our finding that sleep deprivation before extinction learning suggests that adequate sleep is critical for retention of extinction recall. This finding has direct implications for exposure-based treatments for PTSD as well as preventing PTSD. In the treatment scenario, poor sleep, especially before exposure therapy sessions, may significant impair the treatment efficacy of exposure therapy by inhibiting retention of an extinction acquired during the session. Second, it implies that poor sleep after trauma exposure may interfere with naturalist extinction learning, which could increase risk for development of PTSD. These data would suggest that prevention of PTSD may lie in part in supporting adequate sleep (and REM consolidation) after trauma exposure. Our data that REM consolidation may play a role in retention of extinction learning also supports the idea that sleep disturbances (e.g. circadian phase shifts) or drug treatments that suppress REM should be avoided after trauma exposure and certainly in subjects undergoing exposure therapy for PTSD. 6

References See above Appendices Slides of presentations reported in section c. Supporting Data N/A 7

+ The Effect of 36 hours of Total Sleep Deprivation on Extinction Learning and Recall Laura D. Straus, MS Dean Acheson, PhD Victoria Risbrough, PhD Sean P.A. Drummond, PhD Veterans Affairs San Diego Healthcare System University of California, San Diego 8

+ Conflict of Interest Disclosures for Speakers X 1. I do not have any relationships with any entities, health care goods or services consumed by, or used on, patients, 2. I have the following relationships with entities, health care goods or services consumed by, or used on, patients. 3. The material presented in this lecture has no relationship with any of these potential conflicts, 1. 2. 3. 4. This talk presents material that is related to one or more of these potential conflicts, and the following objective references are provided as support for this lecture: 9

+Sleep and Extinction Learning Animal models show fear conditioning: Disrupts sleep Disrupted sleep, in turn Impairs extinction (unlearning of fear) Impairs ability to retain extinction learning In humans, PTSD involves: Sleep disruption Impaired fear and extinction processes Few human studies examining the effect of sleep disruption on extinction processes 10

+Aims and Hypotheses Aim Translational study examining impact of total sleep deprivation (TSD) on extinction learning and recall Hypotheses TSD may impair extinction learning TSD will impair extinction recall 11

+What is Fear Learning? Pair neutral stimulus (blue square) with aversive stimulus (shock) threat signal Do not pair stimulus (yellow square) with shock safety signal 12

+Startle Task Paradigm Fear Conditioning Phase (Day 1) Extinction Learning (Day 2) Extinction Recall (Day 3) 13

+Methods Normal Sleep (n=18) Day 2 Day 3 Night 1 Sleep Extinction Learning Night 2 Sleep Extinction Recall Pre-Extinction Deprivation (n=22) Day 0 Day 1 Day 2 Day 3 Adaptation Night Sleep Adaptation No testing Baseline Sleep Fear Acquisition Night 1 36 hours TSD Extinction Learning Night 2 Sleep Extinction Recall Post-Extinction Deprivation (n=21) Day 2 Day 3 Night 1 Sleep Extinction Learning Night 2 36 hours TSD Extinction Recall Testing was scheduled in the evening each day, 10-12 hours after participants habitual wake time 14

+Subjects & Analyses Subjects (n=61) Age: 23.9 ± 4.6 (range 18-38 y.o.) 39% female Recruited through Internet advertisements, flyers on campus, and word of mouth Screened to be physically healthy and without mental health conditions Sleep regulated 1 week prior to entering lab Restricted from caffeine/alcohol 48 hours prior to lab Analyses Independent samples t-tests to compare Control versus TSD during extinction learning Control versus TSD during extinction recall 15

+ Results Fear Conditioning Startle Response Above Baseline (Z Score) 0.6 0.4 0.2 0.0-0.2-0.4-0.6 Normal Pre-ext Dep Post-ext Dep CS+ CS- * p <.001 16

+Results Extinction Learning Startle to CS+ Above Baseline (Z Score) 1.5 1.0 0.5 0.0-0.5-1.0 Normal Pre-ext Dep Post-ext Dep Early Ext Mid Ext 1 Mid Ext 2 Late Ext Fs < 1, ns 17

+Results Extinction Recall Startle to CS+ Above Baseline (Z Score) 1.0 0.8 0.6 0.4 0.2 0.0 * p <.04 d =.71 Normal Pre-ext Dep Post-ext Dep 18

+Conclusions Sleep Disruption and Extinction Processes TSD prior to extinction did not affect extinction learning TSD prior to extinction affected recall of extinction PTSD Disrupted sleep & nightmares Re-experiencing symptoms in response to trauma-related cues Disrupted sleep may perpetuate the disorder and/or interfere with treatment response Treating sleep = response to PTSD treatment 19

+Acknowledgments DoD grant DM102425 VA San Diego Center of Excellence in Stress and Mental Health Ryan Wong, MA, RPSGT Elisa Tsan William Perrine, RPSGT Anisa Marshall Alexis Alvarez Manuel Campos Christine Phung Yasimin Teheri 20